These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28695669)

  • 1. Risk estimation for biliary tract cancer: Development and validation of a prognostic score.
    Schweitzer N; Fischer M; Kirstein MM; Berhane S; Kottas M; Sinn M; Gonzalez-Carmona MA; Balta Z; Weismüller TJ; Strassburg CP; Reineke-Plaaß T; Bektas H; Manns MP; Johnson P; Weinmann A; Vogel A
    Liver Int; 2017 Dec; 37(12):1852-1860. PubMed ID: 28695669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.
    Berardi R; Mocchegiani F; Pierantoni C; Federici A; Nicolini D; Morgese F; Onofri A; Risaliti A; Vivarelli M; Cascinu S
    Dig Liver Dis; 2013 Jan; 45(1):70-4. PubMed ID: 22999058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.
    Salati M; Caputo F; Cunningham D; Marcheselli L; Spallanzani A; Rimini M; Gelsomino F; Reggiani-Bonetti L; Andrikou K; Rovinelli F; Smyth E; Baratelli C; Kouvelakis K; Kalaitzaki R; Gillbanks A; Michalarea V; Cascinu S; Braconi C
    Eur J Cancer; 2019 Aug; 117():84-90. PubMed ID: 31276980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.
    Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW
    Ann Oncol; 2016 Jan; 27(1):134-40. PubMed ID: 26483051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.
    Neuzillet C; Casadei Gardini A; Brieau B; Vivaldi C; Smolenschi C; Brandi G; Tougeron D; Filippi R; Vienot A; Silvestris N; Pointet AL; Lonardi S; Rousseau B; Scartozzi M; Dahan L; Aprile G; Boussaha T; Malka D; Crusz SM; Le Sourd S; Meurisse A; Lièvre A; Vernerey D; ; ; ;
    Eur J Cancer; 2019 Apr; 111():94-106. PubMed ID: 30826661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
    Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
    Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
    Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
    HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer.
    Park HS; Park JS; Chun YJ; Roh YH; Moon J; Chon HJ; Choi HJ; Park JS; Lee DK; Lee SJ; Yoon DS; Jeung HC
    Cancer Res Treat; 2017 Oct; 49(4):1127-1139. PubMed ID: 28161931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
    Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
    Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in biliary malignancy.
    Groot Koerkamp B; Fong Y
    J Surg Oncol; 2014 Oct; 110(5):585-91. PubMed ID: 25250887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.
    Suzuki S; Kajiyama H; Shimoda M; Shimazaki J; Koike N; Harada N
    Dig Surg; 2017; 34(6):476-482. PubMed ID: 28166534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
    Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
    Filippi R; Montagnani F; Lombardi P; Fornaro L; Aprile G; Casadei-Gardini A; Faloppi L; Palloni A; Satolli MA; Scartozzi M; Citarella F; Lutrino SE; Vivaldi C; Silvestris N; Rovesti G; Rimini M; Aglietta M; Brandi G; Leone F
    Acta Oncol; 2021 Oct; 60(10):1317-1324. PubMed ID: 34282710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for combined resection and reconstruction of the hepatic artery in biliary tract carcinoma].
    Endo I; Masunari H; Sugita M; Morioka D; Tanaka K; Togo S; Sekido H; Yoshida T; Shimada H
    Nihon Geka Gakkai Zasshi; 2001 Nov; 102(11):820-5. PubMed ID: 11729649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.